Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
deals
life sciences
national blog main
national top stories
san diego blog main
3
×
san diego top stories
startups
boston top stories
fda
ipo
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
acetylon pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
ambys medicines
amunix
anirvan ghosh
astrazeneca
atrial fibrillation
biogen
bluerock therapeutics
boston
boston scientific
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cell therapy
cerovene
clinical trial
clinical trials
constellation pharmaceuticals
What
deal
3
×
medicines
startup
acquire
acquisitions
adding
aiming
ambys
announced
atrial
big
bio
biotech
boston
business
ceo
collabs
continues
control
covid
cryterion
daniel
deadly
debuted
device
diseases
fibrillation
formed
future
gilead
gilead’s
heart
help
introduce
ipo
launch
liver
make
management
month
Language
unset
Current search:
" boston blog main "
×
deal
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion